Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Ulipristal Acetate Market by Type (PurityGreater than or equal to98%, PurityGreater than or equal to99%), By Application (Ulipristal Acetate Tablets, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Ulipristal Acetate Market by Type (PurityGreater than or equal to98%, PurityGreater than or equal to99%), By Application (Ulipristal Acetate Tablets, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 143519 3300 Chemical & Material 377 232 Pages 4.9 (47)
                                          

The global ulipristal acetate market is expected to grow at a CAGR of XX% during the forecast period. The growth of this market can be attributed to the increasing number of women who are opting for long-term contraception methods, such as intrauterine devices (IUDs) and contraceptive implants. These contraceptives are considered more effective than oral contraceptives, which have a high failure rate. The global ulipristal acetate market is segmented on the basis of type, application, and region. On the basis of type, it is classified into purity greater than or equal to 98%, purity greater than or equal to 99%. On the basis of application, it is classified into ulipristal acetate tablets. On the basis of region, it is classified into North America (US and Canada), Latin America (Mexico), Europe (Germany and France), Asia Pacific (China and Japan) and Middle East & Africa (Saudi Arabia). -The drug is a type of emergency contraceptive that can be taken up to five days after unprotected sex. -It is not an abortion pill and does not work if the woman is already pregnant. -The drug was approved by the FDA in August 2010 for use as an emergency contraceptive. -In 2013, it was approved for use as a treatment for heavy menstrual bleeding in women who are not pregnant and do not have any other underlying medical conditions that would cause heavy menstrual bleeding.

Industry Growth Insights published a new data on “Ulipristal Acetate Market”. The research report is titled “Ulipristal Acetate Market research by Types (PurityGreater than or equal to98%, PurityGreater than or equal to99%), By Applications (Ulipristal Acetate Tablets, Other), By Players/Companies NewChem, Maiden Group, Hangzhou Think Chemical, Shanghai Acebright, Tapi Teva, Narri, Nanjing Bold Chemical, Symbiotec, Sai Phytoceuticals, Chengdu D-Innovation Pharmaceutical, Shanghai Biliante Bio-Pharmaceutical”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Ulipristal Acetate Market Research Report

By Type

PurityGreater than or equal to98%, PurityGreater than or equal to99%

By Application

Ulipristal Acetate Tablets, Other

By Companies

NewChem, Maiden Group, Hangzhou Think Chemical, Shanghai Acebright, Tapi Teva, Narri, Nanjing Bold Chemical, Symbiotec, Sai Phytoceuticals, Chengdu D-Innovation Pharmaceutical, Shanghai Biliante Bio-Pharmaceutical

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

232

Number of Tables & Figures

163

Customization Available

Yes, the report can be customized as per your need.


Global Ulipristal Acetate Industry Outlook


Global Ulipristal Acetate Market Report Segments:

The global Ulipristal Acetate market is segmented on the basis of:

Types

PurityGreater than or equal to98%, PurityGreater than or equal to99%

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Ulipristal Acetate Tablets, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. NewChem
  2. Maiden Group
  3. Hangzhou Think Chemical
  4. Shanghai Acebright
  5. Tapi Teva
  6. Narri
  7. Nanjing Bold Chemical
  8. Symbiotec
  9. Sai Phytoceuticals
  10. Chengdu D-Innovation Pharmaceutical
  11. Shanghai Biliante Bio-Pharmaceutical

Global Ulipristal Acetate Market Overview


Highlights of The Ulipristal Acetate Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. PurityGreater than or equal to98%
    2. PurityGreater than or equal to99%
  1. By Application:

    1. Ulipristal Acetate Tablets
    2. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Ulipristal Acetate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Ulipristal Acetate Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Ulipristal Acetate is a medication used to prevent pregnancy. Ulipristal acetate works by preventing the release of an egg from the ovary. This prevents fertilization and conception from occurring.

Some of the major companies in the ulipristal acetate market are NewChem, Maiden Group, Hangzhou Think Chemical, Shanghai Acebright, Tapi Teva, Narri, Nanjing Bold Chemical, Symbiotec, Sai Phytoceuticals, Chengdu D-Innovation Pharmaceutical, Shanghai Biliante Bio-Pharmaceutical.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Ulipristal Acetate Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Ulipristal Acetate Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Ulipristal Acetate Market - Supply Chain
   4.5. Global Ulipristal Acetate Market Forecast
      4.5.1. Ulipristal Acetate Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Ulipristal Acetate Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Ulipristal Acetate Market Absolute $ Opportunity

5. Global Ulipristal Acetate Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Ulipristal Acetate Market Size and Volume Forecast by Type
      5.3.1. PurityGreater than or equal to98%
      5.3.2. PurityGreater than or equal to99%
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Ulipristal Acetate Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Ulipristal Acetate Market Size and Volume Forecast by Application
      6.3.1. Ulipristal Acetate Tablets
      6.3.2. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Ulipristal Acetate Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Ulipristal Acetate Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Ulipristal Acetate Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Ulipristal Acetate Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Ulipristal Acetate Demand Share Forecast, 2019-2026

9. North America Ulipristal Acetate Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Ulipristal Acetate Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Ulipristal Acetate Market Size and Volume Forecast by Application
      9.4.1. Ulipristal Acetate Tablets
      9.4.2. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Ulipristal Acetate Market Size and Volume Forecast by Type
      9.7.1. PurityGreater than or equal to98%
      9.7.2. PurityGreater than or equal to99%
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Ulipristal Acetate Demand Share Forecast, 2019-2026

10. Latin America Ulipristal Acetate Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Ulipristal Acetate Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Ulipristal Acetate Market Size and Volume Forecast by Application
      10.4.1. Ulipristal Acetate Tablets
      10.4.2. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Ulipristal Acetate Market Size and Volume Forecast by Type
      10.7.1. PurityGreater than or equal to98%
      10.7.2. PurityGreater than or equal to99%
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Ulipristal Acetate Demand Share Forecast, 2019-2026

11. Europe Ulipristal Acetate Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Ulipristal Acetate Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Ulipristal Acetate Market Size and Volume Forecast by Application
      11.4.1. Ulipristal Acetate Tablets
      11.4.2. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Ulipristal Acetate Market Size and Volume Forecast by Type
      11.7.1. PurityGreater than or equal to98%
      11.7.2. PurityGreater than or equal to99%
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/GrowthPotential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Ulipristal Acetate Demand Share, 2019-2026

12. Asia Pacific Ulipristal Acetate Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Ulipristal Acetate Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Ulipristal Acetate Market Size and Volume Forecast by Application
      12.4.1. Ulipristal Acetate Tablets
      12.4.2. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Ulipristal Acetate Market Size and Volume Forecast by Type
      12.7.1. PurityGreater than or equal to98%
      12.7.2. PurityGreater than or equal to99%
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Ulipristal Acetate Demand Share, 2019-2026

13. Middle East & Africa Ulipristal Acetate Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Ulipristal Acetate Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Ulipristal Acetate Market Size and Volume Forecast by Application
      13.4.1. Ulipristal Acetate Tablets
      13.4.2. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Ulipristal Acetate Market Size and Volume Forecast by Type
      13.7.1. PurityGreater than or equal to98%
      13.7.2. PurityGreater than or equal to99%
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Ulipristal Acetate Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Ulipristal Acetate Market: Market Share Analysis
   14.2. Ulipristal Acetate Distributors and Customers
   14.3. Ulipristal Acetate Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. NewChem
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Maiden Group
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Hangzhou Think Chemical
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Shanghai Acebright
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Tapi Teva
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Narri
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Nanjing Bold Chemical
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Symbiotec
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Sai Phytoceuticals
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Chengdu D-Innovation Pharmaceutical
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Shanghai Biliante Bio-Pharmaceutical
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us